Article Data

  • Views 604
  • Dowloads 143

Case Reports

Open Access

Glassy cell carcinoma: is surgical treatment with preservation of the uterus a therapeutic option

  • N. Habib1,*,
  • T. Dennis2
  • G. Centini3
  • L. Bresson2
  • F. Narducci2
  • E. Leblanc2

1Department of Obstetrics and Gynecology, Beaujon University Hospital, Clichy

2Department of Gynecological Oncology, Oscar Lambert Center, Lille (France)

3Department of Molecular and Developmental Medicine, University of Siena, Siena (Italy)

DOI: 10.31083/j.ejgo.2020.01.5072 Vol.41,Issue 1,February 2020 pp.121-125

Published: 15 February 2020

*Corresponding Author(s): N. Habib E-mail:


Glassy cell carcinoma (GCC) is a rare and aggressive type of adenoSquamous cervical carcinoma. It affects patients at a younger age compared to the general population of patients with cervical cancer. The five-year survival is inferior to that of the other histological types. The treatment is not standardized. Radiation therapy with concomitant chemotherapy is associated with a better local control and improves oncological results. The authors report here the clinical histories of two patients with an early GCC and a desire of fertility preservation treated with radical trachelectomy with an early recurrence. They conclude that considering the rarity and aggressivity of this histological type, and the lack of evidence in the literature for its management, it would be prudent to consider GCC at an early stage as a contraindication for a radical trachelectomy.


Glassy cell carcinoma; Trachelectomy; Cervical cancer; Fertility preservation.

Cite and Share

N. Habib,T. Dennis,G. Centini,L. Bresson, F. Narducci, E. Leblanc. Glassy cell carcinoma: is surgical treatment with preservation of the uterus a therapeutic option. European Journal of Gynaecological Oncology. 2020. 41(1);121-125.


[1] Zolciak-Siwinska A., Jonska-Gmyrek J.: “Glassy cell carcinoma of the cervix: a literature review”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2014, 179, 232.

[2] Costa M.J., Kenny M.B., Hewan-Lowe K., Judd R.: “Glassy cell features in adenosquamous carcinoma of the uterine cervix. Histologic, ultrastructural, immunohistochemical, and clinical findings”. Am. J. Clin. Pathol., 1991, 96, 520.

[3] Hopkins M.P., Morley G.W.: “Glassy cell adenocarcinoma of the uterine cervix”. Am. J. Obstet. Gynecol., 2004, 190, 67.

[4] Littman P., Clement P.B., Henriksen B., Wang C.C., Robboy S.J., Taft P.D., et al.: “Glassy cell carcinoma of the cervix”. Cancer, 1976, 37, 2238.

[5] Maier R.C., Norris H.J.: “Glassy cell carcinoma of the cervix”. Obstet. Gynecol., 1982, 60, 219.

[6] Pak H.Y., Yokota S.B., Paladugu R.R., Agliozzo C.M.: ‘Glassy cell carcinoma of the cervix. Cytologic and clinicopathologic analysis”. Cancer, 1983, 52, 307.

[7] Randall M.E., Kim J.A., Mills S.E., Hahn S.S., Constable W.C.: “Uncommon variants of cervical carcinoma treated with radical irradiation. A clinicopathologic study of 66 cases”. Cancer, 1986, 57, 816.

[8] Guitarte C., Alagkiozidis I., Mize B., Stevens E., Salame G., Lee YC.: “Glassy cell carcinoma of the cervix: a systematic review and meta-analysis”. Gynecol. Oncol., 2014, 133, 186.

[9] Remontet L., Esteve J., Bouvier A-M., Grosclaude P., Launoy G., Menegoz F., et al.: “Cancer incidence and mortality in France over the period 1978-2000”. Rev. Epidemiol. Sante Publique, 2003, 51, 3.

[10] Matthews-Greer J., Dominguez-Malagon H., Herrera G.A., Unger J., Chanona-Vilchis J., Caldito G., et al.: “Human papillomavirus typing of rare cervical carcinomas”. Arch. Pathol. Lab. Med., 2004, 128, 553.

[11] Talerman A., Alenghat E., Okagaki T.: “Glassy cell carcinoma of the uterine cervix”. APMIS, 1991, 23, 119

[12] Zhu H., Li S.: “Glassy cell carcinoma of cervix: a clinicopathologic analysis of 5 cases”. Chinese J. Pathol., 2011, 40, 523.

[13] Chemoradiotherapy for Cervical Cancer Meta-Analysis Collaboration: “Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials”. J. Clin. Oncol., 2008, 26, 5802.

[14] Walji N., Chue A.L., Yap C., Rogers L.J., El-Modir A., Chan K.K., et al.: “Is there a role for adjuvant hysterectomy after suboptimal concurrent chemoradiation in cervical carcinoma?” Clin. Oncol. (R. Coll. Radiol.), 2010, 22, 140.

[15] Ries L.A.G., Harkins D., Krapcho M., Mariotto A., Miller B.A., Feuer E.J., et al. (eds). SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute, 2006, 13, 123.

[16] Gray H.J., Garcia R., Tamimi H.K., Koh W-J., Goff B.A., Greer B.E., et al.: “Glassy cell carcinoma of the cervix revisited”. Gynecol. Oncol., 2002, 85, 274.

[17] Ferrandina G., Salutari V., Petrillo M., Carbone A., Scambi G.: “Conservatively treated glassy cell carcinoma of the cervix”. World J. Surg. Oncol., 2008, 6, 92.

[18] Nahhas W.A., Abt A.B., Mortel R.: “Stage IB glassy cell carcinoma of the cervix with ovarian metastases”. Gynecol. Oncol., 1977, 5, 87.

[19] Reisinger S.A., Palazzo J.P., Talerman A., Carlson J., Jahshan A.: “Stage IB glassy cell carcinoma of the cervix diagnosed during pregnancy and recurring in a transposed ovary”. Gynecol. Oncol., 1991, 42, 86.

[20] Ng W-K., Cheung L.K., Li A.S.: “Liquid-based cytology findings of glassy cell carcinoma of the cervix. Report of a case with histologic correlation and molecular analysis”. Acta Cytol., 2004, 48, 99.

[21] Piura B., Rabinovich A., Meirovitz M., Yanai-Inbar I.: “Glassy cell carcinoma of the uterine cervix”. J. Surg. Oncol., 1999, 72, 206.

[22] Kosiniska-Kaczynska K., Mazanowska N., Bomba-Opon D., Horosz E., Marczewska M., Wielgos M.: “Glassy cell carcinoma of the cervix—a case report with review of the literature”. Ginekol. Pol., 2011, 82, 936.

[23] Watson M., Saraiya M., Benard V., Coughlin S.S., Flowers L., Cokkinides V., et al.: “Burden of cervical cancer in the United States, 1998-2003”. Cancer, 2008, 113, 2855.

[24] Sonoda Y., Chi D.S., Carter J., Barakat R.R., Abu-Rustum N.R.: “Initial experience with Dargent’s operation: the radical vaginal trachelectomy”. Gynecol. Oncol., 2008, 108, 214.

[25] Corney R.H., Crowther M.E., Everett H., Howells A., Shepherd J.H.: “Psychosexual dysfunction in women with gynaecological cancer following radical pelvic surgery”. Br. J. Obstet. Gynaecol., 1993, 100, 73.

[26] Dargent D., Burn J.L., Roy M., Remi I.: “Pregnancies following radical trachelectomy for invasive cervical cancer”. Gynecol. Oncol., 1994, 52, 105.

[27] Dargent D., Burn J.L., Roy M.: “La trachélectomie élargie (T.E.). Une alternative à l hystérectomie radicale dans le traitement des can ́ - cers infiltrants développés sur la face externe du col utérin”. J. Obstet. Gynecol., 1994, 2, 292

[28] Schneider A., Krause N., Kuhne-Heid R., Noschel H.: “Preserving fertility in early cervix carcinoma: trachelectomy with laparoscopic lymphadenectomy”. Zentralbl. Gynakol., 1996, 118, 6.

[29] Roy M., Plante M.: “Pregnancies after radical vaginal trachelectomy for early-stage cervical cancer”. Am. J. Obstet. Gynecol., 1998, 179, 1491.

[30] Shepherd J.H., Crawford R.A., Oram D.H.: “Radical trachelectomy: a way to preserve fertility in the treatment of early cervical cancer”. Br. J. Obstet. Gynaecol., 1998, 105, 912.

[31] Covens A., Shaw P., Murphy J., DePetrillo D., Lickrish G., Laframboise S., et al.: “Is radical trachelectomy a safe alternative to radical hysterectomy for patients with stage IA-B carcinoma of the cervix?” Cancer, 1999, 86, 2273.

[32] Smith J.R., Boyle D.C., Corless D.J., Ungar L., Lawson A.D., Del Priore G., et al.: “Abdominal radical trachelectomy: a new surgical technique for the conservative management of cervical carcinoma”. Br. J. Obstet. Gynaecol., 1997, 104, 1196.

[33] Plante M., Lau S., Brydon L., Swenerton K., LeBlanc R., Roy M.: “Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report”. Gynecol. Oncol., 2006, 101, 367.

[34] Robova H., Pluta M., Hrehorcak M., Skapa P., Rob L.: “High-dose density chemotherapy followed by simple trachelectomy: full-term pregnancy”. Int. J. Gynecol. Cancer, 2008, 18, 1367.

[35] Maneo A., Chiari S., Bonazzi C., Mangioni C.: “Neoadjuvant chemotherapy and conservative surgery for stage IB1 cervical cancer”. Gynecol. Oncol., 2008, 111, 438.

[36] Landoni F., Parma G., Peiretti M., Zanagnolo V., Sideri M., Colombo N., et al.: “Chemo-conization in early cervical cancer”. Gynecol. Oncol., 2007, 107, S125.

[37] Rob L., Charvat M., Robova H., Pluta M., Strnad P., Hrehorcak M., et al.: “Less radical fertility-sparing surgery than radical trachelectomy in early cervical cancer”. Int. J. Gynecol. Cancer, 2007, 17, 304.

[38] Zivanovic O., Leitao M.M.J., Park K.J., Zhao H., Diaz J.P., Konner J., et al.: “Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy”. Gynecol. Oncol., 2009, 112, 590.

[39] Mathevet P., Laszlo de Kaszon E., Dargent D.: “Fertility preservation in early cervical cancer”. Gynecol. Obstet. Fertil., 2003, 31, 706.

[40] Plante M., Renaud M-C., Francois H., Roy M.: “Vaginal radical trachelectomy: an oncologically safe fertility-preserving surgery. An updated series of 72 cases and review of the literature”. Gynecol. Oncol., 2004, 94, 614.

[41] Nishio H., Fujii T., Kameyama K., Susumu N., Nakamura M., Iwata T., et al.: “Abdominal radical trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer in a series of 61 women”. Gynecol. Oncol., 2009, 115, 51.

[42] Sahdev A., Sohaib S.A., Wenaden A.E.T., Shepherd J.H., Reznek R.H.: “The performance of magnetic resonance imaging in early cervical carcinoma: a long-term experience”. Int. J. Gynecol. Cancer, 2007, 17, 629.

[43] Plante M.: “Vaginal radical trachelectomy: an update”. Gynecol. Oncol., 2008, 111, S105.

[44] Carter J., Sonoda Y., Chi D.S., Raviv L., Abu-Rustum N.R.: “Radical trachelectomy for cervical cancer: postoperative physical and emotional adjustment concerns”. Gynecol. Oncol., 2008, 111, 151.

[45] Milliken D.A., Shepherd J.H.: “Fertility preserving surgery for carcinoma of the cervix”. Curr. Opin. Oncol., 2008, 20, 575.

[46] Pahisa J., Alonso I., Torne A.: “Vaginal approaches to fertility-sparing surgery in invasive cervical cancer”. Gynecol. Oncol., 2008, 110, S29.

[47] Chen Y., Xu H., Zhang Q., Li Y., Wang D., Liang Z.: “A fertility-preserving option in early cervical carcinoma: laparoscopy-assisted vaginal radical trachelectomy and pelvic lymphadenectomy”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 136, 90.

[48] Marchiole P., Benchaib M., Buenerd A., Lazlo E., Dargent D., Mathevet P.: “Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent’s operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH)”. Gynecol. Oncol., 2007, 106, 132.

[49] deSouza N.M., Dina R., McIndoe G.A., Soutter W.P.: “Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension”. Gynecol. Oncol., 2006, 102, 80.

[50] Rockall A.G., Sohaib S.A., Harisinghani M.G., Babar S.A., Singh N., Jeyarajah A.R., et al.: “Diagnostic performance of nanoparticleenhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer”. J. Clin. Oncol., 2005, 23, 2813.

[51] Fischerova D., Cibula D., Stenhova H., Vondrichova H., Calda P., Zikan M., et al.: “Transrectal ultrasound and magnetic resonance imaging in staging of early cervical cancer”. Int. J. Gynecol. Cancer, 2008, 18, 766.

[52] Vinh-Hung V., Bourgain C., Vlastos G., Cserni G., De Ridder M., Storme G., et al.: “Prognostic value of histopathology and trends in cervical cancer: a SEER population study”. BMC Cancer, 2007, 7, 164.

[53] Hertel H., Kohler C., Grund D., Hillemanns P., Possover M., Michels W., et al.: “Radical vaginal trachelectomy (RVT) combined with laparoscopic pelvic lymphadenectomy: prospective multicenter study of 100 patients with early cervical cancer”. Gynecol. Oncol., 2006, 103, 506.

[54] Cibula D., Slama J., Fischerova D.: “Update on abdominal radical trachelectomy”. Gynecol. Oncol., 2008, 111, S111.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time